Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy-Reference-Cited by-同舟云学术

Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy

Published:2019-10-14 Issue:3 Volume:17 Page:227-236
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Cai Dongli,Li Jiaming,Liu Dingfeng,Hong Shanjuan,Qiao Qin,Sun Qinli,Li Pingping,Lyu Nanan,Sun Tiantian,Xie Shan,Guo Li,Ni Ling,Jin Liping,Dong Chen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41423-019-0305-2.pdf

Reference45 articles.

1. Thommen, D. S. et al. A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat. Med. 24, 994–1004 (2018).

2. Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252–264 (2012).

3. Mariathasan, S. et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544–548 (2018).

4. Callahan, M. K., Postow, M. A. & Wolchok, J. D. Targeting T cell co-receptors for cancer therapy. Immunity 44, 1069–1078 (2016).

5. Yi, M. et al. Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors. Mol. Cancer 17, 129 (2018).

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response for B7 family using multi-omics data;Life Sciences;2024-09

2. T cell exhaustion and senescence for ovarian cancer immunotherapy;Seminars in Cancer Biology;2024-09

3. CD276 is a promising biomarker for the prognosis of clear cell renal cell carcinoma;The Kaohsiung Journal of Medical Sciences;2024-08-29

4. CD276 Promotes an Inhibitory Tumor Microenvironment in Hepatocellular Carcinoma and is Associated with Poor Prognosis;Journal of Hepatocellular Carcinoma;2024-07

5. Recent advances in understanding the immune microenvironment in ovarian cancer;Frontiers in Immunology;2024-06-05